OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(20)
Publication Date
Release Date
2022
(5)
2025
(4)
2021
(4)
2023
(3)
2026
(2)
2024
(1)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Advances in immunotherapy for cervical cancer.
Not available
S-EPMC10052578
|
biostudies-literature
Cite
Combined Treatment with Immunotherapy-Based Strategies for MSS Metastatic Colorectal Cancer.
Not available
S-EPMC8699573
|
biostudies-literature
Cite
Advances in the systemic treatment of therapeutic approaches in biliary tract cancer.
Not available
S-EPMC9198382
|
biostudies-literature
Cite
Second-event endpoints (EFS2, PRFS2 and PFS2) after anti-PD-(L)1-based RCTs: a systematic review and meta-analysis.
Not available
S-EPMC12666152
|
biostudies-literature
Cite
Optimizing early-phase immunotherapy trials: the role of biomarker enrichment strategies
Not available
S-EPMC12586187
|
biostudies-literature
Cite
Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson's Syndrome: A Case Report.
Not available
S-EPMC8632214
|
biostudies-literature
Cite
Prediction of 90-day mortality among cancer patients with unplanned hospitalisation: a retrospective validation study of three prognostic scores.
Not available
S-EPMC12266187
|
biostudies-literature
Cite
Integrating C-reactive protein flare and early MRI dynamics for enhanced prediction of immunotherapy response.
Not available
S-EPMC12718596
|
biostudies-literature
Cite
Clinical actionability in gliomas revealed by real-world next-generation sequencing: a multicentric study.
Not available
S-EPMC12855890
|
biostudies-literature
Cite
Modification of BRCA1-associated breast cancer risk by HMMR overexpression.
Not available
S-EPMC8989921
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets